|
Portfolio
ChemBridge offers an extensive off-the-self chemistry platform for discovery chemistry programs including:
Collected Screening Libraries - Over 450,000 handcrafted small molecule compounds in stock with new compounds added annually. Our stock compounds are selected using novelty, diversity and druglike property analysis medicinal chemistry expertise.
Combinatorial Libraries – Over 200,000 compounds designed and synthesized in-house to explore pharmacophore space using proprietary building blocks and unpublished novel scaffolds. New compounds added anually.
Building Blocks Collection - A collection of commercially available reagents for the synthesis of advanced molecules for hit-to-lead and lead optimization programs. Over 8,000 Building Blocks are available off the shelf in 1-25g amounts. Over 95% purity by NMR and LCMS is guaranteed on all Building Blocks.
Successful Track Record
Experience - 15 years of excellence as a chemistry service provider/partner, including major, multi-year alliances with top pharmaceutical companies. Click here to view Press Releases
Deliverability - over 10 million samples provided to more than 350 satisfied clients worldwide, including all major pharmaceutical companies. Consistent delivery against CRO project deadlines.
Advanced Leads - obtained by our clients in a variety of HTS programs; numerous examples of success and discoveries published in premier journals, such as Science, Nature Cell Biology, JACS, PNAS, JBC, Cancer Res., etc. Click here to view Publications
Innovations - continuous establishment of new industry standards:
For more information contact sales@chembridge.com.
top of the page |